WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
PULM
PULMATRIX INC
NASDAQ
Biotechnology
$7.00M$1.92-2.49%-$7.50M-0.80x0.60
QNCX
QUINCE THERAPEUTICS INC
NASDAQ
Biotechnology
$34.05M$0.793.68%-$29.85M-1.04x1.15
IGC
IGC PHARMA INC
NYSEMKT
Biotechnology
$28.36M$0.453.01%-$13.52M-1.71x0.24
NUVL
NUVALENT INC
NASDAQ
Biotechnology
$5.10B$79.05-1.26%-$145.13M-32.80x0.05
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$2.04B$8.11-3.80%$725.07M-8.19x1.63
JSPR
JASPER THERAPEUTICS INC
NASDAQ
Biotechnology
$361.90M$23.990.17%-$62.38M-4.28x0.11
ENTA
ENANTA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$284.44M$13.435.09%-$116.18M-2.15x1.49
GHRS
GH RESEARCH PLC
NASDAQ
Biotechnology
$624.34M$12.00-0.08%-$31.27M-19.35x0.04
NKTR
NEKTAR THERAPEUTICS
NASDAQ
Biotechnology
$231.37M$1.264.56%-$144.43M-1.37x2.13
ABVX
ABIVAX SA
NASDAQ
Biotechnology
$886.67M$14.091.00%-$129.52M-3.78x0.67
PIRS
PIERIS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$13.73M$10.403.87%-$15.07M-0.87x0.34
AEZS
AETERNA ZENTARIS INC
NASDAQ
Biotechnology
$8.36M$6.89-5.62%-$16.38M-0.51x1.03
PCVX
VAXCYTE INC
NASDAQ
Biotechnology
$7.90B$72.580.97%-$425.90M-16.96x0.05
INSM
INSMED INC
NASDAQ
Biotechnology
$9.19B$61.873.29%-$637.35M-11.83x-3.49
AFMD
AFFIMED NV
NASDAQ
Biotechnology
$99.44M$6.536.70%-$114.03M-0.85x0.68
RLAY
RELAY THERAPEUTICS INC
NASDAQ
Biotechnology
$959.72M$7.23-3.98%-$323.65M-2.74x0.13
SNGX
SOLIGENIX INC
NASDAQ
Biotechnology
$3.33M$3.37-1.75%-$7.58M-0.29x9.49
CYCC
CYCLACEL PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.71M$1.85-1.60%-$22.70M-0.08x-3.80
PPBT
PURPLE BIOTECH LTD
NASDAQ
Biotechnology
$15.59M$0.584.55%$21.23MN/A0.28
PYPD
POLYPID LTD
NASDAQ
Biotechnology
$7.01M$4.240.00%-$21.05M0.25x-8.33
MOR
MORPHOSYS AG
NASDAQ
Biotechnology
$2.78B$18.43-0.16%-$41.75M-12.26x40.31
CDMO
AVID BIOSERVICES INC
NASDAQ
Biotechnology
$507.20M$7.99-0.87%-$7.83M-28.54x1.53
INMB
INMUNE BIO INC
NASDAQ
Biotechnology
$168.35M$8.51-2.41%-$34.50M-4.43x0.63
IBRX
IMMUNITYBIO INC
NASDAQ
Biotechnology
$4.12B$5.96-4.49%-$439.89M-5.47x-1.58
DOMH
DOMINARI HOLDINGS INC
NASDAQ
Biotechnology
$13.07M$2.183.81%-$24.10M-0.47x0.10
BLRX
BIOLINERX LTD
NASDAQ
Biotechnology
$49.51M$0.682.26%-$44.96M-13.60x2.95
VBIV
VBI VACCINES INC
NASDAQ
Biotechnology
$17.50M$0.614.27%-$74.22M-0.11x-14.80
GNLX
GENELUX CORP
NASDAQ
Biotechnology
$66.41M$2.462.93%-$25.42M-2.54x0.64
ATRA
ATARA BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$67.67M$0.567.66%-$211.11M-0.26x-2.68
ADAP
ADAPTIMMUNE THERAPEUTICS PLC
NASDAQ
Biotechnology
$266.32M$1.040.00%-$151.35M-1.58x9.59
TCRX
TSCAN THERAPEUTICS INC
NASDAQ
Biotechnology
$449.86M$8.51-2.30%-$87.92M-7.21x0.96
BTAI
BIOXCEL THERAPEUTICS INC
NASDAQ
Biotechnology
$53.67M$1.43-0.69%-$139.18M-0.28x-2.14
PTIX
PROTAGENIC THERAPEUTICS INC
NASDAQ
Biotechnology
$4.04M$0.91-5.70%-$5.89M-0.66x0.21
MNMD
MIND MEDICINE (MINDMED) INC
NASDAQ
Biotechnology
$541.20M$7.53-4.32%-$122.00M-2.56x0.41
GNPX
GENPREX INC
NASDAQ
Biotechnology
$5.31M$2.531.61%-$27.61M-0.14x0.44
DAWN
DAY ONE BIOPHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.10B$12.540.40%-$208.53M-5.00x0.10
UBX
UNITY BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$27.37M$1.630.31%-$32.25M-0.71x1.45
KPTI
KARYOPHARM THERAPEUTICS INC
NASDAQ
Biotechnology
$118.89M$1.014.45%-$121.72M-0.80x-2.21
CELC
CELCUITY INC
NASDAQ
Biotechnology
$457.83M$14.663.02%-$67.84M-5.29x0.41
PRLD
PRELUDE THERAPEUTICS INC
NASDAQ
Biotechnology
$220.82M$4.021.52%-$122.31M-2.14x0.17
INZY
INOZYME PHARMA INC
NASDAQ
Biotechnology
$291.96M$4.72-1.05%-$71.14M-3.45x0.49
CDXS
CODEXIS INC
NASDAQ
Biotechnology
$234.25M$3.321.22%-$55.83M-3.57x0.89
VOR
VOR BIOPHARMA INC
NASDAQ
Biotechnology
$85.32M$1.25-3.85%-$112.63M-0.71x0.36
IBIO
IBIO INC
NYSEMKT
Biotechnology
$21.26M$2.472.71%-$21.76M-0.51x1.02
ENLV
ENLIVEX THERAPEUTICS LTD
NASDAQ
Biotechnology
$26.41M$1.424.41%-$28.56M-0.91x0.22
ELEV
ELEVATION ONCOLOGY INC
NASDAQ
Biotechnology
$186.32M$3.41-3.94%-$39.39M-3.48x0.44
ELAB
ELEVAI LABS INC
NASDAQ
Biotechnology
$11.73M$0.62-0.32%N/A-1.68x0.70
BCAB
BIOATLA INC
NASDAQ
Biotechnology
$77.71M$1.628.03%-$118.07M-0.65x0.79
ALXO
ALX ONCOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$445.98M$8.56-1.27%-$163.76M-2.31x0.30
CMND
CLEARMIND MEDICINE INC
NASDAQ
Biotechnology
$3.23M$1.020.00%-$7.85M-0.03x1.00
ADTX
ADITXT INC
NASDAQ
Biotechnology
$3.16M$1.90-0.52%-$34.09M-0.03x1.83
APM
APTORUM GROUP LTD
NASDAQ
Biotechnology
$23.21M$4.48-0.44%-$1.33M-7.23x0.21
SRRK
SCHOLAR ROCK HOLDING CORP
NASDAQ
Biotechnology
$773.61M$9.700.73%-$173.63M-4.64x0.46
TIL
INSTIL BIO INC
NASDAQ
Biotechnology
$70.50M$10.843.53%-$112.47M-0.57x0.49
ALLK
ALLAKOS INC
NASDAQ
Biotechnology
$114.22M$1.29-1.53%-$216.25M-0.52x0.71
COCP
COCRYSTAL PHARMA INC
NASDAQ
Biotechnology
$27.67M$2.727.51%-$15.77M-1.65x0.18
RPHM
RENEO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$57.15M$1.711.79%-$70.26M-0.78x0.04
LCTX
LINEAGE CELL THERAPEUTICS INC
NYSEMKT
Biotechnology
$182.76M$0.974.65%-$22.96M-7.45x0.52
GRI
GRI BIO INC
NASDAQ
Biotechnology
$988.92k$0.26-1.13%-$11.85M0.02x0.64
ANL
ADLAI NORTYE LTD
NASDAQ
Biotechnology
$122.02M$3.31-13.12%-$101.22M-0.46x0.64
QNRX
QUOIN PHARMACEUTICALS LTD
NASDAQ
Biotechnology
$2.94M$0.74-0.14%-$8.31MN/A0.77
RAPT
RAPT THERAPEUTICS INC
NASDAQ
Biotechnology
$128.79M$3.69-3.40%-$114.48M-1.20x0.19
ALVR
ALLOVIR INC
NASDAQ
Biotechnology
$91.54M$0.808.30%-$171.84M-0.48x0.20
ADVM
ADVERUM BIOTECHNOLOGIES INC
NASDAQ
Biotechnology
$151.73M$7.31-2.53%-$96.84M-0.72x0.47
REPL
REPLIMUNE GROUP INC
NASDAQ
Biotechnology
$552.74M$9.000.00%-$206.07M-2.78x0.30
OGEN
ORAGENICS INC
NYSEMKT
Biotechnology
$7.84M$1.754.73%-$20.21M-0.20x0.35
PDSB
PDS BIOTECHNOLOGY CORP
NASDAQ
Biotechnology
$101.23M$2.76-2.13%-$43.60M-2.01x0.86
RLYB
RALLYBIO CORP
NASDAQ
Biotechnology
$67.98M$1.647.54%-$76.13M-0.88x0.11
GOSS
GOSSAMER BIO INC
NASDAQ
Biotechnology
$115.37M$0.51-0.97%-$155.21M-0.51x8.71
TSHA
TAYSHA GENE THERAPIES INC
NASDAQ
Biotechnology
$701.32M$3.75-4.34%-$111.78M-7.65x1.84
XTLB
XTL BIOPHARMACEUTICALS LTD
NASDAQ
Biotechnology
$11.12M$2.04-6.42%-$1.78M-6.80x0.09
CTXR
CITIUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$115.99M$0.644.05%-$35.42M-2.68x0.14
CRIS
CURIS INC
NASDAQ
Biotechnology
$50.63M$8.597.38%-$46.10M-1.00x5.56
ATHA
ATHIRA PHARMA INC
NASDAQ
Biotechnology
$97.74M$2.550.00%-$114.99M-0.84x0.25
ONCY
ONCOLYTICS BIOTECH INC
NASDAQ
Biotechnology
$78.44M$1.041.96%-$20.21M-3.56x0.51
WVE
WAVE LIFE SCIENCES LTD
NASDAQ
Biotechnology
$759.25M$6.205.08%-$53.40M-11.92x7.96
DYN
DYNE THERAPEUTICS INC
NASDAQ
Biotechnology
$2.71B$30.96-1.71%-$255.00M-7.80x0.09
VIRI
VIRIOS THERAPEUTICS INC
NASDAQ
Biotechnology
$4.31M$0.223.70%-$5.07M-0.86x0.22
CALC
CALCIMEDICA INC
NASDAQ
Biotechnology
$56.22M$5.233.36%-$14.88M-2.43x0.57
MNPR
MONOPAR THERAPEUTICS
NASDAQ
Biotechnology
$14.25M$0.825.16%-$7.61M-1.57x0.19
GBIO
GENERATION BIO CO
NASDAQ
Biotechnology
$207.57M$3.124.35%-$163.81M-1.22x1.17
ALNY
ALNYLAM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$19.79B$156.431.93%-$100.79M-59.25x-18.44
DARE
DARE BIOSCIENCE INC
NASDAQ
Biotechnology
$46.91M$0.46-3.33%-$28.77M-1.45x-2.18
AIM
AIM IMMUNOTECH INC
NYSEMKT
Biotechnology
$19.38M$0.38-5.03%-$30.58M-0.59x2.36
IONS
IONIS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$5.79B$39.69-0.25%-$254.76M-14.87x8.32
XNCR
XENCOR INC
NASDAQ
Biotechnology
$1.35B$21.940.23%-$115.26M-10.02x0.44
TSVT
2SEVENTY BIO INC
NASDAQ
Biotechnology
$202.02M$3.930.00%-$213.09M-0.90x1.46
BBIO
BRIDGEBIO PHARMA INC
NASDAQ
Biotechnology
$5.14B$27.48-1.26%-$443.10M-8.53x-1.80
CARM
CARISMA THERAPEUTICS INC
NASDAQ
Biotechnology
$51.51M$1.24-6.77%-$75.99M-0.63x5.77
FRES
FRESH2 GROUP LTD
NASDAQ
Biotechnology
$3.50M$0.39-10.76%N/A-0.12x0.72
BDRX
BIODEXA PHARMACEUTICALS PLC
NASDAQ
Biotechnology
$4.90M$0.96-2.04%-$8.84M-0.10x1.25
BIOR
BIORA THERAPEUTICS INC
NASDAQ
Biotechnology
$25.37M$0.71-3.94%-$100.50M-0.12x-1.23
SYRE
SPYRE THERAPEUTICS INC
NASDAQ
Biotechnology
$1.53B$37.984.08%-$363.77M-0.81x0.54
ENTO
ENTERO THERAPEUTICS INC
NASDAQ
Biotechnology
$5.45M$2.20-6.98%-$20.90M-0.08x0.82
FHTX
FOGHORN THERAPEUTICS INC
NASDAQ
Biotechnology
$253.81M$5.962.41%-$80.43M-2.71x-3.62
ONCT
ONCTERNAL THERAPEUTICS INC
NASDAQ
Biotechnology
$24.74M$8.361.09%-$36.21M-0.68x0.27
RARE
ULTRAGENYX PHARMACEUTICAL INC
NASDAQ
Biotechnology
$3.44B$41.40-1.36%-$585.60M-5.21x8.32
AVTE
AEROVATE THERAPEUTICS INC
NASDAQ
Biotechnology
$640.99M$22.251.78%-$82.03M-7.32x0.18
INAB
IN8BIO INC
NASDAQ
Biotechnology
$61.77M$1.406.87%-$28.50M-1.54x0.46
MREO
MEREO BIOPHARMA GROUP PLC
NASDAQ
Biotechnology
$493.76M$3.521.44%N/AN/A0.31

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 73, which is 50 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 40.25% over the past year, overperforming other biotech stocks by 64 percentage points.

Corcept Therapeutics has an average 1 year price target of $47.67, an upside of 45.37% from Corcept Therapeutics's current stock price of $32.79.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 72, which is 49 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -15.82% over the past year, overperforming other biotech stocks by 8 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $39.80, an upside of 34.05% from Harmony Biosciences Holdings's current stock price of $29.69.

Harmony Biosciences Holdings stock has a consensus Hold recommendation according to Wall Street analysts. Of the 5 analysts covering Harmony Biosciences Holdings, 40% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 20% have issued a Strong Sell.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)


Catalyst Pharmaceuticals (NASDAQ:CPRX) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 30.76% over the past year, overperforming other biotech stocks by 55 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $27.80, an upside of 78.66% from Catalyst Pharmaceuticals's current stock price of $15.56.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 2 biotech stocks that have issued dividends in the past year, the 2 biotech stocks with the highest dividend yields are:

1. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 0.97%, which is the same as the biotech industry average of 0.71%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

2. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.42%, which is the same as the biotech industry average of 0.71%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 25.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.56% in the last day, and up 1.12% over the last week. Corbus Pharmaceuticals Holdings was the among the top gainers in the biotechnology industry, gaining 14.68% yesterday.

Corbus Pharmaceuticals Holdings shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from $77 to $82.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -16.43% in the past year. It has overperformed other stocks in the biotech industry by 7 percentage points.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 71 points higher than the biotech industry average of 15. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -4.22% in the past year. It has overperformed other stocks in the biotech industry by 20 percentage points.

3. Bionomics Limited (NASDAQ:BNOX)


Bionomics Limited (NASDAQ:BNOX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Bionomics Limited has a valuation score of 86, which is 71 points higher than the biotech industry average of 15. It passed 6 out of 7 valuation due diligence checks.

Bionomics Limited's stock has dropped -71.38% in the past year. It has underperformed other stocks in the biotech industry by -48 percentage points.

Are biotech stocks a good buy now?

51.06% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.51% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -3.83x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.